IP Library Patent Application 11901904
Patent Application
App. No. 11/901,904

Methods of inhibiting interleukin-17 receptor

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/901,904
Abstract

Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.

Claims (4)

1 . A method of interfering with Interleukin-17 binding an Interleukin-17 receptor, comprising contacting an antibody that specifically binds SEQ ID NO:10 to a cell expressing a polypeptide comprising SEQ ID NO:10 in the presence of IL-17, wherein said antibody binds said polypeptide and thereby interferes with Interleukin-17 binding to and activating said Interleukin-17 receptor.

2 . The method of claim 1 , wherein said antibody specifically binds the extracellular domain of SEQ ID NO:10.

3 . The method of claim 2 , wherein said antibody specifically binds amino acids 28 through 320 of SEQ ID NO:10.

4 . The method of claims 1 - 3 , wherein said antibody is a monoclonal antibody.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2013
From: AMGEN INC.
To: KIRIN-AMGEN, INC.
Reel/Frame 030045/0876 →